Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience
about
Bacterial infections in cirrhosis: A critical review and practical guidanceAcute-on-chronic liver failureHepatosplanchnic circulation in cirrhosis and sepsisAntibiotics for the treatment of hepatic encephalopathyThe digestive tract as the origin of systemic inflammationThe spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective surveyGut Microbiota and Complications of Liver Disease.Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.No increased risk of herpes zoster found in cirrhotic patients: a nationwide population-based study in Taiwan.Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients.Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.Altered profile of human gut microbiome is associated with cirrhosis and its complications.Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosisAppropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia.New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the LiteratureGut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes MellitusCharacteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition.The Effect of Adrenal Replacement Therapy on Rates of Fungal Colonization and Mortality in Critically Ill Patients Awaiting Liver TransplantationSystemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis.The Worsening Profile of Alcoholic Hepatitis in the United States.Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis.The Clinical Course of Cirrhosis Patients Hospitalized for Acute Hepatic Deterioration: A Prospective Bicentric Study.Practical Concerns and Controversies in the Management of Alcoholic Hepatitis.Risk factors and outcome of bacterial infections in cirrhosisFrailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist.Infections in severe alcoholic hepatitis.Understanding infection susceptibility in patients with acute-on-chronic liver failure.Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: a systematic review and meta-analysis.Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system.Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure.Keeping high model for end-stage liver disease score liver transplantation candidates alive.Clostridium difficile infection in patients with liver disease: a review.Acute kidney injury in acute on chronic liver failure.
P2860
Q26766663-E18DCE9D-CD21-4721-9A0D-9CD536DF0B85Q26859067-51D06645-292A-4339-B686-B5CF27D21776Q26864350-473D48D2-B44D-43F2-BD93-300C4DF23053Q27012878-1F98FBF3-0E26-4F64-9BE6-3D65CEE308CFQ28076873-BF178DCE-9172-4654-AA2D-8D15C2FD1004Q28547409-230F1ECF-A90A-4153-ABC1-77A017CD0EFDQ30236024-B75DFC69-D27D-4655-A721-28AE7333A245Q31049649-EA417EBD-BC67-448A-B119-5178A07B653BQ31156767-CCB8E89D-77B1-40A6-8FD7-FBE3BF22428EQ33701184-38B35C45-A45C-4473-AF95-F390635C23D4Q33831448-F500CB11-F6B1-4BE8-9319-7A3B1713C61CQ34405186-DF17C8D5-32AA-4505-9508-FAD7D8799F72Q34519283-AC2D6288-1D4E-4F9C-8B52-B4A4522F0954Q34861969-29F0EED5-5CB7-48CF-A96A-F480ECCA7528Q35077209-C9C79218-2686-46ED-B1F7-A9B4885E1AD8Q35079589-6D28DE39-566A-4781-96C9-A6D058300FC3Q35221810-A43D816A-24D0-46F0-83C9-71FEE20AD80EQ35565646-759A8F5B-996A-4352-B9B0-1E560193767FQ35587116-FB41F5BB-C892-4EE0-9A62-C70951DB1072Q35875078-BF320DB2-CB2D-418F-B2B4-F88829C4B4FEQ35898936-DC7453DA-2B81-4E66-9C02-5926788A3A66Q35906029-A8C61568-1F77-466E-BAC7-82B17013521CQ35995445-A91EB6ED-87DA-429E-8D21-F2414C76AA76Q36181170-E68F12B6-B42B-45AE-8B23-4B649A132E51Q36472730-88152A67-11AA-46AC-A29A-C45D482F948AQ36691549-D8D9DFDF-6915-499C-A4E4-0F4C34F5F674Q37033009-59AD81C4-21CC-47E6-82EF-DCF605B2B04CQ37049604-89178BAC-66DA-4417-9565-696ABD312E92Q37328532-1D07AD02-4CEC-4F38-A212-906B8E4E0AE6Q37421502-5EAD341A-0274-41F6-ABB3-B62582560794Q37629681-7A1F4BCC-899C-4CC6-9138-75480F4686E8Q37629725-68DDFD13-3DF9-4C53-93B9-B58FF65C1C76Q37657099-DB593390-F29A-43B0-B6E2-189F6C3860B2Q38217984-A50F2067-20DD-4210-A903-B1A39BCA3273Q38336459-1C09A539-1178-489F-8527-6B2C82F4D0AAQ38383499-28677E41-A348-4907-92A7-5226ECDCCC60Q38524991-56C61F80-9CE1-452C-AEA9-E1EC9F2582F9Q38579840-CDB0186E-CB2A-4AD9-9480-3D7D545FBF95Q38600142-41C1EED3-F33F-4781-B8C3-61E03732BBC8Q38608226-C97B0540-D4D6-4DFD-8424-AB9A4B69DA91
P2860
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Second infections independentl ...... r disease (NACSELD) experience
@ast
Second infections independentl ...... r disease (NACSELD) experience
@en
type
label
Second infections independentl ...... r disease (NACSELD) experience
@ast
Second infections independentl ...... r disease (NACSELD) experience
@en
prefLabel
Second infections independentl ...... r disease (NACSELD) experience
@ast
Second infections independentl ...... r disease (NACSELD) experience
@en
P2093
P2860
P921
P356
P1433
P1476
Second infections independentl ...... r disease (NACSELD) experience
@en
P2093
Florence Wong
Geri Brown
Jacqueline G O'Leary
Jasmohan S Bajaj
Jody C Olson
Leroy R Thacker
Nicole A Noble
Patrick S Kamath
Ram M Subramanian
P2860
P304
P356
10.1002/HEP.25947
P407
P577
2012-12-01T00:00:00Z